InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+19.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by GRAHAM PETER J, Directeur Juridique. Director active across 2 companies, notably Antares Pharma, INC.. Cumulatively, 12 reports have been logged. History available since 8 June 2021. The latest transaction was disclosed on 6 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations12 total
221,100 sharesCommon SharesSEC:0001628280-26-047034:0
49,508 shares@ US$3.2923.2% of flowCommon SharesSEC:0001628280-25-056169:0
220,000 shares@ US$1.6156.5% of flowCommon SharesSEC:0001628280-25-005863:0
41,458 shares@ US$3.1320.3% of flowCommon SharesSEC:0001628280-24-050540:0
414,470 shares@ US$5.6074.5% of flowCommon StockSEC:0000899243-22-019789:0
26,044 shares0Common StockSEC:0001016169-22-000031:0
23,068 shares0Common StockSEC:0001016169-22-000016:0
23,068 shares0Common StockSEC:0001016169-22-000016
85,973 shares@ US$4.4210.8% of flowCommon StockSEC:0001209191-21-040328
85,973 shares@ US$4.4210.8% of flowCommon StockSEC:0001209191-21-040328:0
15,996 shares@ US$4.392.0% of flowCommon StockSEC:0001209191-21-039591:0
15,996 shares@ US$4.392.0% of flowCommon StockSEC:0001209191-21-039591
12 of 12 declarations
About GRAHAM PETER J
Peter J. Graham is Executive Vice President, General Counsel, and Secretary at Antares Pharma, Inc. He is responsible for the company's legal affairs and ensures regulatory compliance. His expertise is crucial for protecting the organization's interests.
